HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sunscreen monograph

This article was originally published in The Rose Sheet

Executive Summary

FDA should "move up" anticipated implementation date so standards take effect before 2005, American Academy of Dermatology Association says in April 1 comments. "Proceedings of the UVA consensus conference, summarized in the AADA policy, represent a body of immediately accessible knowledge that should be tapped" and should "substantially shorten the amount of time needed" for FDA to draft a sunscreen monograph amendment, group says. Agency, which postponed Dec. 31, 2002 implementation date to create a comprehensive amendment addressing UVA protection, does not expect a new effective date prior to January 2005 (1"The Rose Sheet" Jan. 7, 2002, p. 3). AADA, Skin Cancer Foundation also urge FDA to remove monograph's SPF "30-plus" cap on labeling...

You may also be interested in...



Sunscreen Monograph Effective Date Extended To Address UVA Standards

The Dec. 31, 2002 implementation date of the OTC sunscreen final monograph has been postponed until further notice for the majority of sunscreens, the agency announces in a 11Dec. 31 Federal Register notice

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010190

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel